Skip to content

Author

C. van der Weyden

We have 2 of 65 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The Development of Non-Tuberculosis Mycobacterial Infections in Sézary Syndrome: A Case Report of Two Patients.

Sézary syndrome (SS) is a rare cutaneous T-cell lymphoma associated with increased risks of opportunistic and atypical infections. This report presents two patients with SS and concurrent non-tuberculosis mycobacterial cutaneous infections. Although rare, difficult to diagnose and challenging to treat, these cases high...

Zachary Warren, Friyana K. Bhabha, Belinda A. Campbell et al. · 0 citations
#gene editing Open access Jul 2026

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

A multiplex prime-editing platform is developed that converts commonly used immunosuppressive drugs into tools for in vivo control of T-cell therapies via defined, pathway-specific drug resistance, enabling selective in vivo modulation in settings where immunosuppression cannot be withdrawn.

E. Bandala-Sanchez, Emma V. Petley, K. Ramsay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.